Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock; No Amount Given

Aegerion Pharmaceuticals, Inc. AEGR today announced that it intends to offer for sale its common stock in an underwritten public offering. All shares in the offering are being sold by Aegerion. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.